MedPath

A study to see the effect of calcium and vitamin D supplementation on the progression of dengue fever to dengue shock syndrome and dengue hemorrhagic fever,

Recruiting
Conditions
Dengue fever [classical dengue]. Ayurveda Condition: DANDAKAH (KEVALAVATA),
Registration Number
CTRI/2024/05/066756
Lead Sponsor
MILIND RAJ NAGVANSHI
Brief Summary

IT IS A RANDOMISED PLACEBO CONTROLLED STUDY EVALUATING THE EFFECT OF CALCIUM AND VITAMIN  D SUPPLEMENTATION ON THE OUTCOME OF DENGUE FEVER . IT IS A PROSPECTIVE , DOUBLE BLINDED ,PLACEBO CONTROLLED SINGLE CENTRE RANDOMIZED CONTROL TRIAL

ALL RANDOMIZED ADMITTED PATIENTS OF DENGUE FEVER WILL BE PLACED EITHER ON ORAL CALCIUM 500MG BD FOR 15 DAYS OR ORAL CHOLECALCIFEROL4000 IU PER DAY FOR 15 DAYS FROM DATE OF ADMISSION ALONG WITH STANDARD THERAPY

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
120
Inclusion Criteria

Patient with acute dengue fever confirmed by lab investigations , all patients wiling to give informed consent, all acute dengue fever patient admitted to medicine wards /CCW/ICU at jnmch.

Exclusion Criteria

Age more than 60 yr and pregnant females, patient presenting with dengue shock syndrome and dengue hemorrhagic fever, diagnosed comorbid conditions like known case of Type2DM, syst HTN,cancer,active TB, hyperparathyroidism,hypothyroidism,osteoporosis,CKD,CLD,COPD,CAD,CARDIOMYOPATHY,MALABSORPTION,history of allergy from study medication, patients not giving consent for study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
TO EVALUATE THE EFFECT OF CALCIUM AND VITAMIN D SUPPLEMENTATION ON ADMITTED ACUTE DENGUE FEVER PATIENT ON THEIR PROGRESSION TO DSS AND DHFTO EVALUATE THE EFFECT OF CALCIUM AND VITAMIN D SUPPLEMENTATION ON ADMITTED ACUTE DENGUE FEVER PATIENT ON THEIR PROGRESSION TO DSS AND DHF
Secondary Outcome Measures
NameTimeMethod
Progressive worsening of thrombocytopenia,major and minor bleeding episodes,hepatopathy,hypocalcemia,shock,respiratory failure,acute kidney injury,cardiac arrhythmias,encephalopathy,capillary leakageProgressive worsening of thrombocytopenia,major and minor bleeding episodes,hepatopathy,hypocalcemia,shock,respiratory failure,acute kidney injury,cardiac arrhythmias,encephalopathy,capillary leakage

Trial Locations

Locations (1)

Jawaharlal Nehru medical college and hospital Aligarh Muslim University

🇮🇳

Aligarh, UTTAR PRADESH, India

Jawaharlal Nehru medical college and hospital Aligarh Muslim University
🇮🇳Aligarh, UTTAR PRADESH, India
Milind raj nagvanshi
Principal investigator
8419051230
milindrajnagvanshi@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.